Mednet Logo

What is your approach to patients with SLE who develop a rash after hydroxychloroquine initiation?

3 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)
Answered on · Updated on

First, I diagnose the type of rash.

If it is a severe cutaneous reaction, e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis (SJS/TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), or if it is a more persistent type of reaction like a lichenoid reaction, I stop hydroxychlor...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Dermatology · Duke Health
Answered on

From a dermatologist's perspective, I strongly consider that the diagnosis might be dermatomyositis, rather than lupus. Up to 30% of dermatomyositis patients develop a morbilliform drug rash in response to hydroxychloroquine (and DM sine myositis or clinically minimal myositis is frequently misdiagn...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · U.S. Department of Veterans Affairs
Answered on

Also, let’s not forget that HCQ can cause skin toxicity: I've seen many follow-up patients on chronic HCQ with the grey discoloration has promoted a dose reduction or discontinuation discussion for some as most RA and on much better med TNF or CSDMARD MTX/Lef equivalent.

Join for free or sign in to see the full answer